Pradel, Bernadeth P.

HRN: 21-70-86  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/14/2022
CEFUROXIME 750MG (VIAL)
08/15/2022
08/21/2022
IV
1.5G
On Call To OR Then Q8
Primary LTCS
Waiting Final Action 
08/16/2022
CEFUROXIME 500MG (TAB)
08/16/2022
08/22/2022
ORAL
500mg
BID
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: